⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REPL News
Replimune Group, Inc.
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Replimune Group Inc. (REPL) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
REPL
Securities Fraud Investigation Into Replimune Group Inc. (REPL) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
globenewswire.com
REPL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
accessnewswire.com
REPL
Form 8-K
sec.gov
REPL
Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma
globenewswire.com
REPL
Bragar Eagel & Squire, P.C. is Investigating Replimune Group Inc. on Behalf of Replimune Stockholders and Encourages Investors to Contact the Firm
globenewswire.com
REPL
Bronstein, Gewirtz & Grossman, LLC Encourages Replimune Group Inc. (REPL) Investors to Inquire about Securities Investigation
accessnewswire.com
REPL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
prnewswire.com
REPL
Form 8-K
sec.gov
REPL
REPL INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
globenewswire.com
REPL